• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Structural modification on rupestonic acid leads to highly potent inhibitors against influenza virus

tetano

Editor, Senior Moderator
Mol Divers. 2018 Jul 3. doi: 10.1007/s11030-018-9840-5. [Epub ahead of print]
[h=1]Structural modification on rupestonic acid leads to highly potent inhibitors against influenza virus.[/h] Obul M[SUP]1,[/SUP][SUP]2[/SUP], Wang X[SUP]1,[/SUP][SUP]2[/SUP], Zhao J[SUP]1[/SUP], Li G[SUP]1[/SUP], Aisa HA[SUP]3[/SUP], Huang G[SUP]4[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Influenza viruses are responsible for seasonal epidemics and occasional pandemics, which cause significant morbidity and mortality. Although several drugs (adamantanes and neuraminidase inhibitors) are available in the market, the worldwide spread of drug-resistant influenza strains poses an urgent need for novel antiviral drugs. Artemisia rupestris L. is a folk medicine used to treat cold. In this paper, we structurally modified rupestonic acid, a bioactive component of A. rupestris, to synthesize a series of 2-substituted rupestonic acid methyl esters (3a-3o). Their structures were fully characterized by [SUP]1[/SUP]H NMR, [SUP]13[/SUP]C NMR, HRMS spectra. Among them, compounds 3b and 3c exhibited potent activities against influenza H1N1 with micromolar IC[SUB]50[/SUB] values and might serve as new lead compounds for the treatment of influenza.


[h=4]KEYWORDS:[/h] Artemisia rupestris; Benzylation; Influenza virus; Rupestonic acid

PMID: 29971616 DOI: 10.1007/s11030-018-9840-5
 
Back
Top Bottom